AzTrials
AzTrials

Dry EyeNCT07297849

Eyelid Closure in Keratometry

A study testing Eyelid closure for 3 minutes in people with Dry Eye and Ocular Surface Disease, run by Vienna Institute for Research in Ocular Surgery at 1 site in Austria.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Cataract surgery is one of the most common performed surgeries in the world. While in the early beginnings of cataract surgery, visual rehabilitation was the main goal of the procedure, refractive outcome and subsequent relative spectacles independency is gaining increasing importance in patients' demands. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Dry Eye, Ocular Surface Disease
What is being tested?
Eyelid closure for 3 minutes
Could I receive a placebo?
No, everyone receives an active treatment
How many people
29 participants
Where
1 siteAustria
Study dates
7 Nov 2024to 31 Dec 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18 or older
  • Written informed consent
  • Keratometry quality index "warning"

Who cannot join

  • Severe corneal conditions that may compromise corneal integrity (such as corneal scarring, etc.)
  • Pregnancy (pregnancy test will be taken in women of reproductive age), nursing women
  • Ocular surgery in the study eye in the three months preceding the study
  • Inability of visual fixation (e.g. in patients with nystagmus)
  • Inability of eyelid closure (e.g. in patients with facial nerve paralysis)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Andreas Schlatter, MD contact

+43 1 91021 57564

office@viros.at

Austria1 site, 1 recruiting
  • Vienna Institute for Research in Ocular Surgery (VIROS), Department of Ophthalmology

    Vienna, State of Vienna, 1140

    Manuel Ruiss, MSc, +43 1 91021- 57564, office@viros.at

    office@viros.at

    Recruiting

Other trials in Austria

About this study

Official title: The Effect of Eyelid Closure on the Quality Index of Keratometric Measurements: a Non-controlled Interventional Study

Cataract surgery is one of the most common performed surgeries in the world. While in the early beginnings of cataract surgery, visual rehabilitation was the main goal of the procedure, refractive outcome and subsequent relative spectacles independency is gaining increasing importance in patients' demands. Due to the improvements in measurement techniques and prediction formulas, the prediction of postoperative refraction is possible with high accuracy. However, there are still some sources of error that lead to deviations of predicted postoperative refraction. For instance, it was shown that tear film osmolarity, an established biomarker for dry eye disease (DED), plays an important role in preoperative precision of keratometry measurements. Keratometry, the measurement of corneal curvature, is an important part of preoperative biometry. Errors in preoperative keratometry measurements lead to nearly one-to-one deviations from the predicted refraction. Therefore, proper keratometry measurements are a key element in intraocular lens (IOL) power calculations. To counteract the issue of DED in preoperative biometry, the principle of using lubricating eye drops before ocular biometry has been investigated and it was shown that the use of ocular lubricants may lead to increased variability of keratometry measurements. From our clinical observations, another possible mechanism to improve keratometry is eyelid closure for some minutes. In contrast to the long-term use of ocular lubricants to stabilize the tear film, eyelid closure is an easy and fast intervention to possibly improve the precision of keratometry measurements. Additionally, a clinical trial investigating the usage of lubricating eye drops for two weeks found no improvement of variability of keratometry in DED patients.

Therefore, this study aims to investigate the effect of eyelid closure on the quality index of keratometric measurements in patients with a warning for the quality of keratometric measurements. For this purpose, a single study day including 4 repeated measurements (2 without and 2 with lid closure for 3 minutes) using an ocular biometer (IOLMaster700) will be performed.

Being tested
Eyelid closure for 3 minutes
Medical subject headings
Dry Eye Syndromes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Eyelid closure for 3 minutesBehavioural

    Patients will be advised to close their eyes for 3 minutes before the third and before the fourth study measurement.

Study groups in NCT07297849
Study groupRoleWhat they receive
Patients with a keratometrical warning indexExperimentalThe following measurements will be performed in the mentioned order during the visit 1 only in the randomized study eye: 1. First and second biometry using IOLMaster® 700 (2x, 3 minutes pause between the measurements, eyes open, normal blinking) 2. Eyelid closure for 3 minutes 3. Third biometry using IOLMaster® 700 (1x) right after opening of the eyelid 4. Eyelid closure for 3 minutes 5. Fourth biometry using IOLMaster® 700 (1x) right after opening of the eyelid
Receives: Behavioral: Eyelid closure for 3 minutes

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Difference in discordant pairs of keratometry quality warnings between the first and third measurement

    As the outcome is binary (successful measurement vs. measurement with a warning/failed), the difference in discordant pairs of keratometry quality warnings between the first and third measurement

    Measured: Baseline measurement (time: 0 minutes) to third study measurement (time: approximately after 6 minutes - after 3 minutes of eyelid closure) at the same study day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Dec 2025
  2. Study start7 Nov 2024
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Sequential
Masking
None (open label)
Enrolment
29 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07297849
Sponsor's protocol ID
EK 24-111-0824
Status last verified
Dec 2025
First submitted
2 Dec 2025
Last updated
22 Dec 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: The data that support the findings of this study are available after study completion from the corresponding author upon reasonable request.

Questions about this trial

What is this clinical trial studying?

A study testing Eyelid closure for 3 minutes in people with Dry Eye and Ocular Surface Disease, run by Vienna Institute for Research in Ocular Surgery at 1 site in Austria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 22 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Austria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Andreas Schlatter, MD (+43 1 91021 57564, office@viros.at), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Difference in discordant pairs of keratometry quality warnings between the first and third measurement (time frame: Baseline measurement (time: 0 minutes) to third study measurement (time: approximately after 6 minutes - after 3 minutes of eyelid closure) at the same study day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in